Health News

Breast cancer patients and their families will rally together on Tuesday, June 28, at 7:00 am outside of the Federal Drug Administration (FDA). At issue will be the FDA’s final hearing to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer, despite the FDA approving it in 2008 for use to treat breast cancer.

Read more

Filed under: Pharmacy News
Tags: Breast Cancer, cancer, Drug, Pharmacy

Related posts

• Zoledronic acid may extend survival in older breast cancer patients (0)
  A drug used to protect bone may extend survival in older breast cancer patients, according to researchers at the Universities of Sheffield and Leeds. Read more [tags] Pharmacy News [/tags]
  
  
• Women at high risk of developing breast cancer reluctant to take tamoxifen for prevention (0)
  Even when women at high-risk of breast cancer are well-informed about the risks and benefits of using the drug tamoxifen for prevention, only 6 percent said they were likely to take it. Read more [tags] Pharmacy News [/tags]
  
  
• USPTO issues patent covering method of metastatic breast cancer treatment using Bionovo’s Bezielle (0)
  Bionovo, Inc. announced today that the US Patent and Trademark Office (USPTO) has issued a patent covering a method of using Bionovo's proprietary drug candidate Bezielle® (BZL101) for the treatment of metastatic breast cancer. The patent issued today is Bionovo's second issued patent, with over 70 other patent applications currently pending. Read more [tags] Pharmacy News [/tags]
  
  
• US Oncology Research Network Participates In Phase III Follow-up Study To BiPar’s Investigational Cancer Drug BSI-201 (0)
  US Oncology, Inc. today announced that US Oncology Research will participate in the BiPar Sciences' Phase III, Multi-center, Open-Label, Randomized Trial of Gemcitabine/Carboplatin (G/C), with or without BSI-201, in patients with Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2-negative metastatic breast cancer. Joyce O'Shaughnessy, M.D. Read more [tags] Pharmacy News [/tags]
  
  
• Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients (0)
  In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer. Read more [tags] Pharmacy News [/tags]